Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3M Innovative Properties Company is the intellectual property management subsidiary of 3M, responsible for the global patent and trademark portfolio of the conglomerate. In the healthcare and life sciences sectors, it holds critical patents related to medical devices, wound care, oral care, and drug delivery systems, including metered-dose inhalers and transdermal patches. While 3M recently spun off its dedicated healthcare division into the independent company Solventum, 3M Innovative Properties remains a central entity for the parent company's ongoing materials science innovations that intersect with health applications. The company's portfolio includes foundational technologies in adhesives, filtration, and antimicrobial coatings used extensively in clinical settings. Its expertise in microreplication and non-woven materials continues to drive advancements in bioprocessing and clinical diagnostics. The company's technologies are widely licensed and integrated into products across the pharmaceutical and medical device industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3M Innovative Properties.